Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion type Assertion NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_head.
- NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion description "[Selective BRAF inhibitors have now been established as a standard of care option for patients diagnosed with metastatic melanoma whose tumors carry a BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_provenance.
- NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion evidence source_evidence_literature NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_provenance.
- NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion SIO_000772 23770823 NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_provenance.
- NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion wasDerivedFrom befree-2016 NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_provenance.
- NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_assertion wasGeneratedBy ECO_0000203 NP1086276.RA6zpeougJW0yc5LTbTX7YEMz9MS6eh8wIyZgGZesa37Q130_provenance.